New Protein Fund I supports 17 alternative protein start-ups
With money from its $50m New Protein Fund, Big Idea Ventures funds in 17 pre-seed plant-based, cell-based and microbial food, ingredient and technology companies.
Sibylla Biotech raises 23m Series A
Verona-based Sibylla Biotech has closed a 23m Series A financing round to advance its Pharmacological Protein Inactivation by Folding Intermediate Targeting (PPI-FIT) platform.
AI expert XUND GmbH bags 6m seed financing
Austrian XUND GmbH wants to use the assets of a 6m seed financing to grow in Germany, Switzerland and Austria.
ADC makeer Pheon Therapeutics raises $68m
Antibody-Drug Conjugate (ADC) specialist Pheon Therapeutics Ltd. has closed a $68m Series A financing co-led by Brandon Capital, Forbion and Atlas Venture.
Kupando raises 13m to push TLR4/7 agonist
Kupando has raised 13m in Series A financing co-led by Remiges Ventures and LifeCare Partners to initiate clinical development of KUP101.
DAMAN P/S enters personal RA medicine project
Danish AI health app developer DAMAN P/S has entered the 12m EU-funded Squeeze project, that aims to find stratification biomarkers for DMARDs in rheumatoid arthritis (RA).
AI specialist Quinten Health bags 14m financing
Quinten Groups French healthcare arm Quinten Health has closed a financing round to advance disease modeling platforms and virtual twins in real-world.
Bavarian Nordic expands vaccine contract by $234m
Bavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options.
Food specialist Standing Ovation SA raises 12m
Foodtech startup Standing Ovation SA has closed an oversubscribed 12m Series A financing round led by Astanor Ventures.
HeartBeat.bio inks partnership with Molecular Devices
HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening